Our innovative products and technologies are designed to meet current and future demands for medical radioisotopes. They mark a new era for nuclear medicine technology.
Medical radioisotopes are critical to meet patient healthcare needs and advance clinical research. We’ve charted the course for producing a stable, reliable and domestically sourced isotope supply.
Our people drive our solutions. From providing domestic supply of isotopes for patients to national security and environmental sustainability, we are committed to advancing radioisotope technology to shape a better world.
NorthStar Medical Radioisotopes’ Response to COVID-19
Production of Radioisotopes is Classified as an Essential Function. In Conjunction with Our Partners at the University of Missouri Research Reactor (MURR®), We Continue to Operate at Full Capacity in Producing Domestic Mo-99 for the United States.
NorthStar Continues to Hire and Onboard New Employees as Planned.
We hope this message finds each of you in good health and doing everything necessary to keep yourself and your families and loved ones safe.
All NorthStar operations have implemented CDC precautions to protect our employees and customers and to avoid spreading the COVID-19 virus. As we transition back to having more employees in our facilities, we continue to practice social distancing, use face masks/coverings when necessary, clean and disinfect work areas, adhere to advised hygiene practices and work remotely as local conditions may warrant.
We are in close contact with our radiopharmacy customers during this time, who are undergoing their own significant challenges in continuing to provide radioisotope supply to hospitals and patients. NorthStar remains fully available, continuing to strive to exceed customer expectations during this challenging time.
© Copyright NorthStar Medical Technologies. All rights reserved. Terms & Conditions Privacy Policy Site Map